The arrival of artificial intelligence (AI) has injected growth into various companies and raised long-term expectations, ...

Five-year, 10-year, and multi-decade charts of market movements all show that stock market sell-offs happen. No one knows ...

Investing large sums of money can be nerve-racking. This can be particularly true when building a growth-focused portfolio.

The technology companies nicknamed the "Magnificent Seven" have a combined value of $17.2 trillion, which represents ...

Capital returns are a driving force for markets and central to the stocks on this list. These stocks pay significant dividends, repurchase shares robustly, or both, and insider bu ...

Valuation metrics highlight Ford’s appeal to bargain hunters, with a P/E of 11.07 and a forward P/E of just 5.74. For income seekers, Ford’s 6.18% dividend yield is particularly enticing. Technically, ...

The five-year stock chart tells the story. UPS stock reached a record high in 2021 that lasted into 2022. However, as higher inflation and interest rates impacted consumer budgets, the company has ...

it can be difficult to narrow down what stocks should be on your buy list as we start a new year. Here are three of my favorites right now. In short, Reddit is delivering in a big way in its first ...

The year ahead should be a decent one for stock markets. The global economy may not be red hot right now, but at least growth is in the cards. But this year could also be a transitional one, with ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 2nd: Robinhood Markets, Inc. HOOD: This operator of a financial services platform ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 23: Twilio Inc. TWLO: This customer engagement platform provider carries a Zacks ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 24: Puma Biotechnology, Inc. PBYI: This biopharmaceutical company has a Zacks Rank ...